NCT04723953View on ClinicalTrials.gov

Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

August 25, 2022

Study Completion Date

September 30, 2022

Conditions
Myocardial Remodeling After AMI
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI PET/MRI

PET and MRI in patients with acute myocardiac infarction are simultaneously analyzed using hybrid PET/MRI device for monitoring myocardial fibrosis and function.

Trial Locations (1)

200025

Shanghai Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT04723953 - Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR | Biotech Hunter | Biotech Hunter